Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Sheaff Brock Investment Advisors LLC

Sheaff Brock Investment Advisors LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 12,010 shares of the medical equipment provider’s stock after selling 20 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in Intuitive Surgical were worth $6,269,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of ISRG. Creative Planning raised its holdings in shares of Intuitive Surgical by 9.3% during the third quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock valued at $33,839,000 after buying an additional 5,842 shares during the last quarter. Secure Asset Management LLC increased its position in Intuitive Surgical by 6.0% in the 3rd quarter. Secure Asset Management LLC now owns 1,534 shares of the medical equipment provider’s stock valued at $754,000 after acquiring an additional 87 shares during the period. Trust Co. of Vermont raised its stake in Intuitive Surgical by 1.4% during the 3rd quarter. Trust Co. of Vermont now owns 5,120 shares of the medical equipment provider’s stock valued at $2,515,000 after acquiring an additional 71 shares in the last quarter. Onyx Bridge Wealth Group LLC acquired a new position in Intuitive Surgical during the 3rd quarter worth $402,000. Finally, Howard Capital Management Group LLC grew its stake in shares of Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,348 shares of company stock valued at $3,587,582. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on ISRG. Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Up 0.7 %

ISRG opened at $595.55 on Friday. The firm has a market capitalization of $212.12 billion, a P/E ratio of 92.91, a PEG ratio of 5.67 and a beta of 1.39. The stock has a fifty day moving average of $559.48 and a 200-day moving average of $519.06. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.